Publications by authors named "Kakeru Hisakane"

Claim this Profile
P
Palliative surgery is effective in patients with -mutant lung adenocarcinoma with pleural metastasis.
Yue Liu, Yifei Zhou, Shuangyi Li, Qianxin Zhou, Jun Li, Kakeru Hisakane

Transl Lung Cancer Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allergic bronchopulmonary mycosis induced by pembrolizumab for bladder cancer: A case report.
Hiroki Iida, Kenichiro Atsumi, Naohiro Kadoma, Sae Takashima, Yukari Shirakura, Kakeru Hisakane

Respir Med Case Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ivermectin Enhances Paclitaxel Efficacy by Overcoming Resistance Through Modulation of in Non-small Cell Lung Cancer.
Anna Hayashi, Koichiro Kamio, Akihiko Miyanaga, Keisuke Yoshida, Rintaro Noro, Kakeru Hisakane

Anticancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlations between 14-gene RNA-level assay and clinical and molecular features in resectable non-squamous non-small cell lung cancer: a cross-sectional study.
Zhicheng Huang, Ming Zhao, Bowen Li, Jianchao Xue, Yadong Wang, Kakeru Hisakane

Transl Lung Cancer Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histopathologic pattern and molecular risk stratification are associated with prognosis in patients with stage IB lung adenocarcinoma.
Weiran Liu, Chen Chen, Qiang Zhang, Jiping Xie, Xinyi Wu, Kakeru Hisakane

Transl Lung Cancer Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of atezolizumab plus bevacizumab, carboplatin, and paclitaxel combination for the treatment of advanced non-squamous non-small cell lung cancer patients with malignant pleural effusion.
Kakeru Hisakane, Kenichiro Atsumi, Masahiro Seike, Takashi Hirose

Transl Lung Cancer Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Gefitinib Administration After Osimertinib-Induced Interstitial Lung Disease: A Six-Case Series.
Kaoruko Shimbu, Kakeru Hisakane, Naohiro Kadoma, Shunichi Nishima, Kenichiro Atsumi

Onco Targets Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of sarcoidosis with multiple bone lesions using both bone scintigraphy and FDG-PET/CT: A case report.
Naohiro Kadoma, Kenichiro Atsumi, Kaoruko Shinbu, Shunichi Nishima, Kakeru Hisakane

Respir Med Case Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer.
Takehiro Tozuka, Rintaro Noro, Hideaki Mizutani, Futoshi Kurimoto, Taiki Hakozaki, Kakeru Hisakane

Lung Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung Cancer.
Yoko Tsukita, Takehiro Tozuka, Kohei Kushiro, Shinobu Hosokawa, Toshiyuki Sumi, Kakeru Hisakane

JAMA Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal effective dose of maintenance steroid therapy for relapse of cryptogenic organizing pneumonia.
Kenichiro Atsumi, Kakeru Hisakane, Erika Mikami, Takahiro Suzuki, Satoru Matsuki

Respir Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroid transcription factor-1 (TTF-1) expression and the efficacy of combination therapy with immune checkpoint inhibitors and cytotoxic chemotherapy in non-squamous non-small cell lung cancer.
Hirokazu Iso, Kakeru Hisakane, Erika Mikami, Takahiro Suzuki, Satoru Matsuki

Transl Lung Cancer Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A remarkable response to combination chemotherapy with nivolumab and ipilimumab in a patient with primary pulmonary choriocarcinoma: a case report.
Hirokazu Iso, Kakeru Hisakane, Naoki Terashi, Erika Mikami, Satoru Matsuki

Transl Cancer Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platinum-combination chemotherapy with or without immune-checkpoint inhibitor in patients with postoperative recurrent non-small cell lung cancer previously treated with adjuvant platinum-doublet chemotherapy: A multicenter retrospective study.
Kakeru Hisakane, Takehiro Tozuka, Satoshi Takahashi, Namiko Taniuchi, Nobuhiko Nishijima

Thorac Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of eosinophilic pneumonia from eosinophilic bronchiolitis without asthma: A case report.
Erika Mikami, Kenichiro Atsumi, Hirokazu Iso, Takahiro Suzuki, Satoru Matsuki, Kakeru Hisakane

Respir Med Case Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum-derived exosomal miR-125a-3p predicts the response to anti-programmed cell death-1/programmed cell death-ligand 1 monotherapy in patients with non-small cell lung cancer.
Kakeru Hisakane, Masahiro Seike, Teppei Sugano, Kuniko Matsuda, Takeru Kashiwada

Gene· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active pulmonary interstitial fibrosis in a COVID-19 survivor diagnosed by transbronchial lung cryobiopsy six months after onset.
Yutaka Muto, Koji Okudela, Atsuhito Nakazawa, Kakeru Hisakane, Mai Matsumura

Hum Pathol Rep· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Black pleural effusion caused by a pancreaticopleural fistula associated with autoimmune pancreatitis: A case report.
Keiki Miyadera, Kakeru Hisakane, Yuki Kato, Kenichiro Atsumi, Hiroki Ono

Medicine (Baltimore)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carboplatin plus nanoparticle albumin-bound paclitaxel for the treatment of thymic carcinoma.
Akiko Takahashi, Rintaro Noro, Natsuki Takano, Kakeru Hisakane, Satoshi Takahashi

Mol Clin Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Molecular Target in -mutant Lung Cancer Treated With the Combination of Osimertinib and Pemetrexed.
Natsuki Takano, Masahiro Seike, Teppei Sugano, Kuniko Matsuda, Kakeru Hisakane

Anticancer Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exosome-derived miR-210 involved in resistance to osimertinib and epithelial-mesenchymal transition in EGFR mutant non-small cell lung cancer cells.
Kakeru Hisakane, Masahiro Seike, Teppei Sugano, Akiko Yoshikawa, Kuniko Matsuda

Thorac Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 Expression Status Predicting Survival in Pulmonary Pleomorphic Carcinoma.
Kakeru Hisakane, Masahiro Seike, Teppei Sugano, Kuniko Matsuda, Shinobu Kunugi

Anticancer Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and utility of transbronchial cryobiopsy in precision medicine for lung cancer: Prospective single-arm study.
Hibiki Udagawa, Keisuke Kirita, Tomoyuki Naito, Shogo Nomura, Masayuki Ishibashi, Kakeru Hisakane

Cancer Sci· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitor-associated interstitial lung diseases correlate with better prognosis in patients with advanced non-small-cell lung cancer.
Teppei Sugano, Masahiro Seike, Yoshinobu Saito, Takeru Kashiwada, Yasuhiro Terasaki, Kakeru Hisakane

Thorac Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly paclitaxel in combination with carboplatin for advanced non-small-cell lung cancer complicated by idiopathic interstitial pneumonias: a single-arm phase II study.
Aya Fukuizumi, Yuji Minegishi, Miwako Omori, Kenichiro Atsumi, Natsuki Takano, Kakeru Hisakane

Int J Clin Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis